4.1 Article

Flow cytometry analysis of endothelial cells and subsets of exhausted CD8+ T cells in murine tumor models

期刊

STAR PROTOCOLS
卷 3, 期 2, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.xpro.2022.101444

关键词

-

资金

  1. Fondation ARC pour la Recherche sur le Cancer [SL220110603471, PGA 120150202411, PGA1 RF20180206911]
  2. Institut National du Cancer [INCa_2013-098, INCa_2017-155]
  3. Agence Nationale de la Recherche [ANR-12-BSV1-0006-01]
  4. IDEX UNITI
  5. Laboratoire d'Excellence Toulouse Cancer (LABEX TOUCAN)
  6. LABEX TOUCAN
  7. Fondation ARC [DOC20170505820]
  8. French Ministry of Research
  9. Fondation pour la Recherche Medicale [FRM FDT20160435636, ECO201806006827, ECO202006011469, FDT202106012889]
  10. Agence Nationale de la Recherche (ANR) [ANR-12-BSV1-0006] Funding Source: Agence Nationale de la Recherche (ANR)

向作者/读者索取更多资源

This article presents a protocol for flow cytometry analysis of endothelial cells (ECs) and CD8+ T cells in murine tumor models, including baseline and post-immunotherapy analysis. The protocol is valuable for studying rare subsets of cells that play critical roles in antitumor immunity.
Here, we present a protocol for flow cytometry analysis of endothelial cells (ECs) and CD8+ T cells in murine tumor models, at baseline and after cancer immuno-therapy with anti-PD-1/anti-CTLA-4 antibodies. We provide gating strategies for identification of specific cell subsets including ECs from tumor-associated high endothelial venules (TA-HEVs), stem-like, and terminally exhausted CD8+ T cells. This protocol represents a valuable tool for the analysis of rare subsets of tumor ECs and CD8+ T cells with critical roles in antitumor immunity.For complete details on the use and execution of this protocol, please refer to Asrir et al. (2022).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据